Journal Information
Vol. 46. Issue S2.
1º Congresso CancerThera
Pages S3 (April 2024)
Vol. 46. Issue S2.
1º Congresso CancerThera
Pages S3 (April 2024)
Full text access
DUAL TIME PSMA PET/CT WITH DIURETICS AND CONTRAST TO DETECT PROSTATE CANCER PELVIC METASTASES: IS THERE A BENEFIT?
Visits
786
Thais Do Amaral Tognolia, Mariana Camachob, Allan Santosa, Mariana Limaa, Wagner Matheusa, Ubirajara Ferreiraa, Elba Cristina Sá de Camargo Etchebeherea
a Universidade Estadual de Campinas (Unicamp), Campinas, SP, Brazil
b MND Campinas, Campinas, SP, Brazil
This item has received
Article information
Special issue
This article is part of special issue:
Vol. 46. Issue S2

1º Congresso CancerThera

More info
Introduction/Justification

The renal excretion of PSMA radiotracer may render PSMA PET/CT imaging interpretation difficult to identify local recurrence and lymph node metastases in prostate cancer patients.

Objectives

To evaluate the best acquisition method to increase the detection rate of local recurrence and pelvic metastases on PSMA PET/CT by performing dual time-point imaging (delayed imaging) after hyperhydration, diuretics, and contrast enhancement.

Materials and Methods

Patients with prior history of prostate adenocarcinoma underwent PSMA PET/CT for primary staging or due to biochemical recurrence. PSMA PET/CT acquisition consisted of delayed pelvic imaging after hyperhydration, diuretics, and excretory-phase contrast. SUV values obtained in local recurrence lesions, locoregional lymph node metastases, and bone metastases in the early and delayed PSMA PET/CT images were compared.

Results

A total of 182 patients (medians: age = 66.5; Gleason score = 7.0; total PSA = 1.5) underwent PSMA PET/CT. Twenty-one patients (12%) were scanned due to primary staging, and 161 patients due to biochemical recurrence (88%). Delayed images (with only hyperhydration, without contrast or diuretics) increased diagnostic certainty in identifying local recurrence in 26.6% of patients and locoregional lymph nodes in 25%. There was a significant increase in SUV values in the delayed images compared to early images in the local recurrence (p < 0.0001), locoregional lymph node metastases (p < 0.0001), and bone metastases (p < 0.0199). Adding excretory-phase contrast to the delayed images increased diagnostic certainty in identifying local recurrence in 9.4% of patients and locoregional lymph nodes in 8.3%. The use of diuretics only in delayed images (without excretory-phase contrast) increased diagnostic certainty in identifying local recurrence in 14% of patients; while for identifying pelvic lymph nodes increase was only mild (2.8%). The association of diuretics with excretory-phase contrast increased the diagnostic certainty in identifying local recurrence in 15.6% of patients and locoregional lymph nodes in 5.6%.

Conclusion

Delayed PSMA PET/CT images increase the diagnostic certainty of identifying local recurrence and locoregional metastases in prostate cancer patients. The addition of diuretics increases diagnostic certainty and may be useful in selected cases. However, the addition of excretory-phase contrast (regardless of the use of diuretics) only mildly impacted diagnostic certainty and may be omitted.

Keywords:
Câncer de prostata
PET-CT imaging
PSMA
Full text is only available in PDF
Download PDF
Idiomas
Hematology, Transfusion and Cell Therapy
Article options
Tools